Overview
- 34 inspections across 34 sites are on record.
- 8 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-22.
At a glance
Inspections
34
Sites
34
Observations
8
Career since
Jul 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Tamatha F. Zemzars, M.D. | 22 May 2026 | Human Drugs | |
| Fadi E. Saba, M.D. | 24 Apr 2026 | Human Drugs | |
| Lidia R. Bermudez, M.D. | 19 Mar 2026 | Human Drugs | |
| Brien E. Pierpont, M.D. | 26 Feb 2026 | Human Drugs | On file |
| Jolan E. Walter, M.D., Ph.D. | 30 Jan 2026 | Biologics |
Sites inspected
Tamatha F. Zemzars, M.D.Saint Petersburg, United States1 insp.
Fadi E. Saba, M.D.Saint Petersburg, United States1 insp.
Lidia R. Bermudez, M.D.Tampa, United States1 insp.
Brien E. Pierpont, M.D.Saint Petersburg, United States1 insp.
Jolan E. Walter, M.D., Ph.D.St Petersburg, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Ana P Barido3 shared
Emily A Baldwin2 shared
Scott B Laufenberg2 shared
Valerie L Kelesyan1 shared
Richard A Lyght1 shared
Full investigator report
Get the verbatim findings behind Chinyere A Asanya's 8 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site